PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 18, 2026Cardiology in Review3 citations

Diagnostic Performance of Artificial Intelligence-Assisted Echocardiography in Identifying Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis

View Full Paper
SSShayan ShojaeiMNMohammad Ali NazariNGNegar Ghasemloo

Key Result

AI-assisted echocardiography demonstrated a pooled AUC of 0.96 for identifying hypertrophic cardiomyopathy, with sensitivity of 0.89 and specificity of 0.87.

Key Points

  • To evaluate the diagnostic performance of AI-assisted echocardiography for identifying hypertrophic cardiomyopathy (HCM).
  • Performed a systematic review and meta-analysis
  • Included studies reporting diagnostic metrics like sensitivity and specificity
  • Pooled data using a bivariate random-effects model
  • Evaluated heterogeneity using the I2 statistic
  • Analyzed 25 eligible studies
  • Pooled area under the curve (AUC) was 0.93 (95% CI, 0.90–0.95)
  • After correction, pooled AUC improved to 0.96 (95% CI, 0.93–0.97)
  • Sensitivity of AI-based echocardiography was 0.89 (95% CI, 0.83–0.93)
  • Specificity was 0.87 (95% CI, 0.76–0.94)
  • Convolutional neural networks showed higher sensitivity compared to other algorithms.

Structured PICO

Does artificial intelligence-assisted echocardiography accurately identify hypertrophic cardiomyopathy?

P
Population
25 studies evaluating patients for hypertrophic cardiomyopathy (HCM) using echocardiography
I
Intervention
Artificial intelligence (AI)-assisted echocardiography interpretations (including convolutional neural networks, support vector machines, and ensemble learning algorithms)
O
Outcome
Diagnostic performance measured by area under the curve (AUC), sensitivity, and specificitysurrogate

Artificial intelligence-assisted echocardiography demonstrates high diagnostic accuracy for identifying hypertrophic cardiomyopathy, highlighting its potential to improve clinical decision-making.

Abstract

Hypertrophic cardiomyopathy (HCM), the most common genetic cardiac disease, remains underdiagnosed most of the time due to overlapping echocardiographic characteristics and subjective interpretations. This systematic review and meta-analysis aimed to assess the diagnostic performance of artificial intelligence (AI)-assisted echocardiography interpretations for identifying HCM and to explore factors contributing to variability and validity. After a comprehensive search through various databases, eligible studies reporting diagnostic metrics such as sensitivity, specificity, or area under the curve (AUC) were included into our analyses. Data were pooled using a bivariate random-effects model, and heterogeneity was quantified with the I 2 statistic. Twenty-five studies were included into our meta-analysis. The pooled AUC for AI-based echocardiographic detection of HCM was 0.93 95% confidence interval (CI), 0.90–0.95. After trim-and-fill correction, the pooled AUC increased to 0.96 (95% CI, 0.93–0.97). Overall sensitivity and specificity were 0.89 (95% CI, 0.83–0.93) and 0.87 (95% CI, 0.76–0.94), respectively. Meta-regression revealed that convolutional neural network, support vector machine, and ensemble learning algorithms exhibited variable performance, with convolutional neural network-based models favoring higher sensitivity. We demonstrated that AI-based models evaluating echocardiographic data could be an accurate diagnostic tool for HCM. This highlights the potential of recent advancements to improve clinical decision-making.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Shojaei et al. (2026) studied this question. AI-assisted echocardiography demonstrated a pooled AUC of 0.96 for identifying hypertrophic cardiomyopathy, with sensitivity of 0.89 and specificity of 0.87.

synapsesocial.com/papers/696c77d4eb60fb80d13960b6https://doi.org/10.1097/crd.0000000000001172
Ask AI
Helpful
Bookmark
Share
View Full Paper